Biotech Agios Reports Second Quarter 2026 Financial Results and Provides Business Update July 30, 2026
Biotech Pharming reports second quarter and first half 2026 financial results and revises year-end guidance; strong Joenja momentum and near-term clinical readouts to support broader therapeutic use July 30, 2026
Biotech Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 6, 2026 July 29, 2026
Biotech AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Non-Segmental Vitiligo July 29, 2026
Biotech AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults and Adolescents with Severe Alopecia Areata July 29, 2026
Biotech Immatics Announces Upcoming Presentations Across Its PRAME Franchise at ESMO Congress 2026 July 17, 2026
Biotech Cosmos Health Share Buyback Surpasses $1 Million, Reaching 4.84 Million Shares; Continues Open Market Repurchases July 16, 2026
Biotech HERVolution Therapeutics Presents Clinical Evidence of HERV-K Driving Metabolic Senescence at the International Congress on Obesity 2026 July 15, 2026
Search
Biotech
July 30, 2026
July 30, 2026
July 30, 2026
July 29, 2026
July 29, 2026
July 29, 2026
July 29, 2026
July 17, 2026
July 16, 2026
July 15, 2026
